Octreotide for injectable suspension; Good manufacturing practices concerns
Why it was recalled
Product quality
What you should do
If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement product. If you are unsure whether your product is affected, check with your pharmacy.Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects.Return affected product(s) to the pharmacy where it was purchased for proper disposal.Consult a health care professional if you have used the affected product and have health concerns.Contact Teva Canada Limited by calling toll-free at 1-800-268-4127, option 3, or by email at druginfo@tevacanada.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
Other Recent Recalls
Apo-Semaglutide Injection
Apo-Semaglutide Injection : Incorrect dose display
Moderate health risk
Novo-Gesic Forte 500 mg tablets (acetaminophen)
Generic acetaminophen by Teva recalled because it may contain foreign material
Highest health risk
JAMP Temozolomide
JAMP Temozolomide: Out-of-Specification (Assay)
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.